New Methods and Reagents for Small Scale Synthesis of Phosphor Organic Compounds with Focus on the Phosphonic Acids and Their Analogues
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Phosphorus Oxychloride CAS No
Product Safety Summary Phosphorus Oxychloride CAS No. 10025-87-3 This Product Safety Summary is intended to provide a general overview of the chemical substance. The information in the summary is basic information and is not intended to provide emergency response information, medical information or treatment information. The summary should not be used to provide in-depth safety and health information. In-depth safety and health information can be found in the Safety Data Sheet (SDS) for the chemical substance. Names Phosphorus oxychloride Phosphorus trichloride oxide Phosphoric trichloride POCl 3 Product Overview Solvay Novecare does not sell phosphorus oxychloride directly to consumers. Phosphorus oxychloride (POCl3) is used as a chemical intermediate to produce a variety of products which are used in several applications including manufacture of triarylphosphate esters which are used as flame retardants as well as an intermediate in the production of pharmaceutical, textile and agricultural chemicals. Phosphorus oxychloride is used in industrial applications and other processes where workplace exposures can occur. Consumer exposure does not occur as phosphorus oxychloride is not used in any commercially available product. Phosphorus oxychloride is dangerous to human health. Phosphorus oxychloride may be fatal if inhaled, highly toxic if swallowed, harmful if absorbed through skin and can cause severe burns which may result in scarring. Phosphorus oxychloride is consumed in manufacturing processes. POCl3 can make its way into the environment through unintentional releases (spills). POCl3 will not bioaccumulate but is not biodegradable. POCl3 in higher concentrations can be harmful to aquatic life due to formation of acids from the hydrolysis of POCl3. When released into the atmosphere, phosphorus oxychloride exists as vapor. -
Sulfonyl-Containing Nucleoside Phosphotriesters And
Sulfonyl-Containing Nucleoside Phosphotriesters and Phosphoramidates as Novel Anticancer Prodrugs of 5-Fluoro-2´-Deoxyuridine-5´- Monophosphate (FdUMP) Yuan-Wan Sun, Kun-Ming Chen, and Chul-Hoon Kwon†,* †Department of Pharmaceutical Sciences, College of Pharmacy and Allied Health Professions, St. John’s University, Jamaica, New York 11439 * To whom correspondence should be addressed. Department of Pharmaceutical Sciences, College of Pharmacy and Allied Health Professions, St. John’s University, 8000 Utopia parkway, Jamaica, NY 11439. Tel: (718)-990-5214, fax: (718)-990-6551, e-mail: [email protected]. Abstract A series of sulfonyl-containing 5-fluoro-2´-deoxyuridine (FdU) phosphotriester and phosphoramidate analogues were designed and synthesized as anticancer prodrugs of FdUMP. Stability studies have demonstrated that these compounds underwent pH dependent β-elimination to liberate the corresponding nucleotide species with half-lives in the range of 0.33 to 12.23 h under model physiological conditions in 0.1M phosphate buffer at pH 7.4 and 37 °C. Acceleration of the elimination was observed in the presence of human plasma. Compounds with FdUMP moiety (4-9) were considerably more potent than those without (1-3) as well as 5-fluorouracil (5-FU) against Chinese hamster lung fibroblasts (V-79 cells) in vitro. Addition of thymidine (10 µM) reversed the growth inhibition activities of only 5-FU and the compounds with FdUMP moiety, but had no effect on those without. These results suggested a mechanism of action of the prodrugs involving the intracellular release of FdUMP. Introduction 5-Fluoro-2´-deoxyuridine-5´-monophosphate (FdUMP) is the major metabolite responsible for the anticancer activity of 5-FU (Chart 1). -
5 Phosphorus Oxychloride1 Acute Exposure Guideline Levels
Acute Exposure Guideline Levels for Selected Airborne Chemicals: Volume 10 Committee on Acute Exposure Guideline Levels Committee on Toxicology Board on Environmental Studies and Toxicology Division on Earth and Life Studies Copyright © National Academy of Sciences. All rights reserved. Acute Exposure Guideline Levels for Selected Airborne Chemicals: Volume 10 THE NATIONAL ACADEMIES PRESS 500 FIFTH STREET, NW WASHINGTON, DC 20001 NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Insti- tute of Medicine. The members of the committee responsible for the report were chosen for their special competences and with regard for appropriate balance. This project was supported by Contract No. W81K04-06-D-0023 and EP-W-09-007 be- tween the National Academy of Sciences and the U.S. Department of Defense and the U.S. Environmental Protection Agency. Any opinions, findings, conclusions, or recom- mendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the organizations or agencies that provided support for this project. International Standard Book Number-13: 978-0-309-21987-7 International Standard Book Number-10: 0-309-21987-6 Additional copies of this report are available from The National Academies Press 500 Fifth Street, NW Box 285 Washington, DC 20055 800-624-6242 202-334-3313 (in the Washington metropolitan area) http://www.nap.edu Copyright 2011 by the National Academy of Sciences. -
Toxicological Profile for Glyphosate Were
A f Toxicological Profile for Glyphosate August 2020 GLYPHOSATE II DISCLAIMER Use of trade names is for identification only and does not imply endorsement by the Agency for Toxic Substances and Disease Registry, the Public Health Service, or the U.S. Department of Health and Human Services. GLYPHOSATE III FOREWORD This toxicological profile is prepared in accordance with guidelines developed by the Agency for Toxic Substances and Disease Registry (ATSDR) and the Environmental Protection Agency (EPA). The original guidelines were published in the Federal Register on April 17, 1987. Each profile will be revised and republished as necessary. The ATSDR toxicological profile succinctly characterizes the toxicologic and adverse health effects information for these toxic substances described therein. Each peer-reviewed profile identifies and reviews the key literature that describes a substance's toxicologic properties. Other pertinent literature is also presented, but is described in less detail than the key studies. The profile is not intended to be an exhaustive document; however, more comprehensive sources of specialty information are referenced. The focus of the profiles is on health and toxicologic information; therefore, each toxicological profile begins with a relevance to public health discussion which would allow a public health professional to make a real-time determination of whether the presence of a particular substance in the environment poses a potential threat to human health. The adequacy of information to determine a substance's -
NPR72: the Pavlodar Chemical Weapons Plant in Kazakhstan
GULBARSHYN BOZHEYEVA Report The Pavlodar Chemical Weapons Plant in Kazakhstan: History and Legacy GULBARSHYN BOZHEYEVA Gulbarshyn Bozheyeva holds a Ph.D. degree in Chemical Physics from the Kazakh State University. From 1996-97, she was a Visiting Scholar and Research Associate at the Center for Nonproliferation Studies at the Monterey Institute of International Studies. She is now completing a master’s degree in International Development Policy at Duke University. he former Soviet Union’s chemical weapons theless, manufacturing lines and equipment for primary (CW) program consisted of many production and intermediate CW precursors and buildings for fill- plants that created the world’s largest stockpile ing CW munitions were constructed at Pavlodar. The T 1 of chemical weapons. Most of the CW production and plant also acquired personnel with expertise in CW pro- storage facilities were located in Russia, but a few fa- duction.5 cilities existed in other Soviet republics. In recent years, This report is devoted to the role of the Pavlodar Western countries have provided significant financial Chemical Plant in the former Soviet CW program and assistance for dismantling former CW facilities in Rus- its current status. The first part of the report describes sia and converting former CW production facilities for the history of the Pavlodar plant and its military and 2 commercial use. Although a fair amount has been writ- civilian infrastructures. The second part deals with the ten about Russian CW facilities, little is known about CW capability of the plant and the nature of the chemi- the CW programs in other former Soviet republics. -
United States Patent Office Patented Oct
3,346,562 United States Patent Office Patented Oct. 10, 1967 2 3,346,562 cg METHOD FOR THE PRODUCTION OF PO-CE Base RBONUCLEOSDE-5'-PHOSPHATE / O Mikio Honjo, Takatsuki, and Ryuji Maremoto, Minoo, Cl EO Japan, assignors to Takeda Chemical industries, Ltd., Osaka, Japan No Drawing. Filed May 31, 1966, Ser. No. 553,718 Claims priority, application Japan, May 29, 1965, R. X R. 40/31,814 9 Claims. (Cl. 260-21.5) HO. O. BIO O 10 N1 N1 This invention is concerned with a method for the pro Po-H, Base Po-H, Base duction of ribonucleoside-5'-phosphate. EIO k" wE+ EO k". Ribonucleoside-5'-phosphate is very useful as condi H HO - ment for food and also in the pharmaceutical industry, O O OH OH and has been chemically produced by at first protecting 15 X the hydroxyl groups at the 2'- and 3'-positions of its ribose R1 R2 moiety with acyl or isopropylidene groups and then phos phorylating the 5'-hydroxyl group of the thus-protected RN compound with pentavalent phosphorus compound such C=O: aliphatic ketone or aromatic aldehyde as phosphorus pentachloride, phosphorus oxychloride, 20 R?2 etc., followed by removing the protecting groups. As "ribonucleoside' in the present method there are However, this hitherto-known method requires a long used those containing purine base such as adenosine, time (about 7 to about 30 hours) for completing the pro inosine, etc. or those containing pyrimidine base such as tection and phosphorylation, and therefore is not desirable uridine, cytidine, etc. As the aliphatic ketone having 3 from an industrial viewpoint. -
(12) Patent Application Publication (10) Pub. No.: US 2005/0044778A1 Orr (43) Pub
US 20050044778A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2005/0044778A1 Orr (43) Pub. Date: Mar. 3, 2005 (54) FUEL COMPOSITIONS EMPLOYING Publication Classification CATALYST COMBUSTION STRUCTURE (51) Int. CI.' ........ C10L 1/28; C1OL 1/24; C1OL 1/18; (76) Inventor: William C. Orr, Denver, CO (US) C1OL 1/12; C1OL 1/26 Correspondence Address: (52) U.S. Cl. ................. 44/320; 44/435; 44/378; 44/388; HOGAN & HARTSON LLP 44/385; 44/444; 44/443 ONE TABOR CENTER, SUITE 1500 1200 SEVENTEENTH ST DENVER, CO 80202 (US) (57) ABSTRACT (21) Appl. No.: 10/722,127 Metallic vapor phase fuel compositions relating to a broad (22) Filed: Nov. 24, 2003 Spectrum of pollution reducing, improved combustion per Related U.S. Application Data formance, and enhanced Stability fuel compositions for use in jet, aviation, turbine, diesel, gasoline, and other combus (63) Continuation-in-part of application No. 08/986,891, tion applications include co-combustion agents preferably filed on Dec. 8, 1997, now Pat. No. 6,652,608. including trimethoxymethylsilane. Patent Application Publication Mar. 3, 2005 US 2005/0044778A1 FIGURE 1 CALCULATING BUNSEN BURNER LAMINAR FLAME VELOCITY (LFV) OR BURNING VELOCITY (BV) CONVENTIONAL FLAME LUMINOUS FLAME Method For Calculating Bunsen Burner Laminar Flame Velocity (LHV) or Burning Velocity Requires Inside Laminar Cone Angle (0) and The Gas Velocity (Vg). LFV = A, SIN 2 x VG US 2005/0044778A1 Mar. 3, 2005 FUEL COMPOSITIONS EMPLOYING CATALYST Chart of Elements (CAS version), and mixture, wherein said COMBUSTION STRUCTURE element or derivative compound, is combustible, and option 0001) The present invention is a CIP of my U.S. -
744 Hydrolysis of Chiral Organophosphorus Compounds By
[Frontiers in Bioscience, Landmark, 26, 744-770, Jan 1, 2021] Hydrolysis of chiral organophosphorus compounds by phosphotriesterases and mammalian paraoxonase-1 Antonio Monroy-Noyola1, Damianys Almenares-Lopez2, Eugenio Vilanova Gisbert3 1Laboratorio de Neuroproteccion, Facultad de Farmacia, Universidad Autonoma del Estado de Morelos, Morelos, Mexico, 2Division de Ciencias Basicas e Ingenierias, Universidad Popular de la Chontalpa, H. Cardenas, Tabasco, Mexico, 3Instituto de Bioingenieria, Universidad Miguel Hernandez, Elche, Alicante, Spain TABLE OF CONTENTS 1. Abstract 2. Introduction 2.1. Organophosphorus compounds (OPs) and their toxicity 2.2. Metabolism and treatment of OP intoxication 2.3. Chiral OPs 3. Stereoselective hydrolysis 3.1. Stereoselective hydrolysis determines the toxicity of chiral compounds 3.2. Hydrolysis of nerve agents by PTEs 3.2.1. Hydrolysis of V-type agents 3.3. PON1, a protein restricted in its ability to hydrolyze chiral OPs 3.4. Toxicity and stereoselective hydrolysis of OPs in animal tissues 3.4.1. The calcium-dependent stereoselective activity of OPs associated with PON1 3.4.2. Stereoselective hydrolysis commercial OPs pesticides by alloforms of PON1 Q192R 3.4.3. PON1, an enzyme that stereoselectively hydrolyzes OP nerve agents 3.4.4. PON1 recombinants and stereoselective hydrolysis of OP nerve agents 3.5. The activity of PTEs in birds 4. Conclusions 5. Acknowledgments 6. References 1. ABSTRACT Some organophosphorus compounds interaction of the racemic OPs with these B- (OPs), which are used in the manufacturing of esterases (AChE and NTE) and such interactions insecticides and nerve agents, are racemic mixtures have been studied in vivo, ex vivo and in vitro, using with at least one chiral center with a phosphorus stereoselective hydrolysis by A-esterases or atom. -
High-Threat Chemical Agents: Characteristics, Effects, and Policy Implications
Order Code RL31861 CRS Report for Congress Received through the CRS Web High-Threat Chemical Agents: Characteristics, Effects, and Policy Implications Updated September 9, 2003 Dana A. Shea Analyst in Science and Technology Policy Resources, Science, and Industry Division Congressional Research Service ˜ The Library of Congress High-Threat Chemical Agents: Characteristics, Effects, and Policy Implications Summary Terrorist use of chemical agents has been a noted concern, highlighted after the Tokyo Sarin gas attacks of 1995. The events of September 11, 2001, increased Congressional attention towards reducing the vulnerability of the United States to such attacks. High-threat chemical agents, which include chemical weapons and some toxic industrial chemicals, are normally organized by military planners into four groups: nerve agents, blister agents, choking agents, and blood agents. While the relative military threat posed by the various chemical types has varied over time, use of these chemicals against civilian targets is viewed as a low probability, high consequence event. High-threat chemical agents, depending on the type of agent used, cause a variety of symptoms in their victims. Some cause death by interfering with the nervous system. Some inhibit breathing and lead to asphyxiation. Others have caustic effects on contact. As a result, chemical attack treatment may be complicated by the need to identify at least the type of chemical used. Differences in treatment protocols for the various high-threat agents may also strain the resources of the public health system, especially in the case of mass casualties. Additionally, chemical agents trapped on the body or clothes of victims may place first responders and medical professionals at risk. -
United States Patent (19) 11 Patent Number: 6,028, 182 Uhlmann Et Al
US006028182A United States Patent (19) 11 Patent Number: 6,028, 182 Uhlmann et al. (45) Date of Patent: *Feb. 22, 2000 54 METHYLPHOSPHONIC ACID ESTERS, Roelen, “Synthesis of alkylphosphon(othio)ate analogues of PROCESSES FOR THEIR PREPARATION, DNA.” Tetrahedron Letters, vol. 33, 1992, pp. 2357–2360. AND THEIR USE Meier, “O-Alkyl-5", 5'-dinucleoside-phosphates as com bined prodrugs of antiviral and antibiotic compounds,” 75 Inventors: Eugen Uhlmann, Glashütten; Chris Bioorganic Med. Chem. Lett., vol. 1, 1991, pp. 527-530. Meier, Bad Homburg, both of Germany Chris Meier et al., Lipophilic C-Hydroxybenzylphospho 73 Assignee: Hoechst Aktiengesellschaft, Frankfurt nates as Prodrugs of 3'-Azido-2, 3-dideoxythymidine am Main, Germany (AZT), Liesbigs Ann. 1995, 2195-2202. Chris Meier et al., Homo * Notice: This patent issued on a continued pros Dinucleoside-C-Hydroxyphoshonate Diesters as Prodrugs ecution application filed under 37 CFR of the Antiviral Nuceloside Analogues 2',3'-Dideoxythy 1.53(d), and is subject to the twenty year midine and 3'-Azido-2',3'-Dideoxythymidine, Nucelosides patent term provisions of 35 U.S.C. & Nucelositeda, 14(3-5), 759–762 (1995). 154(a)(2). Chris Meier, Lipohilic 5', 5-0-Dinucleoside-O-hydroxybenzylphophonic Acid 21 Appl. No.: 08/578,686 Esters as Potential Prodrugs of 2, 3'-Dideoxythymidine 22 PCT Filed: Jun. 29, 1994 (ddT), Agnew. Chemical Int. Ed. Engl 1993, vol. 32, No. 12, pp. 1704-1706. 86 PCT No.: PCT/EP94/02121 Yoshino et al. “Organic phosphorus compounds. 2. Synthe S371 Date: Jan. 2, 1996 sis and coronary vasodilator activity of (benzothiazolylben Zyl)phosphonate derivatives.” J. -
Asymmetric Synthesis of Organophosphates and Their
ASYMMETRIC SYNTHESIS OF ORGANOPHOSPHATES AND THEIR DERIVATIVES Thesis Submitted to The College of Arts and Sciences of the UNIVERSITY OF DAYTON In Partial Fulfillment of the Requirements for The Degree of Master of Science in Chemistry By Batool J. Murtadha Dayton, Ohio May 2020 ASYMMETRIC SYNTHESIS OF ORGANOPHOSPHATES AND THEIR DERIVATIVES Name: Murtadha, Batool J. APPROVED BY: __________________________________ Jeremy Erb, Ph.D. Research Advisor Assistant Professor Department of Chemistry University of Dayton ___________________________________ Vladimir Benin, Ph.D. Professor of Chemistry Department of Chemistry University of Dayton ___________________________________ Justin C. Biffinger, Ph.D. Committee Member Assistant Professor Department of Chemistry University of Dayton ii © Copyright by Batool J. Murtadha All rights reserved 2020 iii ABSTRACT ASYMMETRIC SYNTHESIS OF ORGANOPHOSPHATES AND THEIR DERIVATIVES Name: Murtadha, Batool J. University of Dayton Advisor: Dr. Jeremy Erb Organophosphorus compounds (OPs) are widely used in the agricultural industry especially in the pesticide market. Phosphates play a huge role as biological compounds in the form of energy carrier compounds like ATP, and medicine as antivirals. OPs have become increasingly important as evidenced by the publication of new methods devoted to their uses and synthesis. These well-established studies lay the basis for industrial organic derivatives of phosphorus preparations. The current work explored methods of synthesizing chiral organophosphate triesters. We experimented with different processes roughly divided into either an electrophilic or nucleophilic strategy using chiral Lewis acids, organocatalysts (HyperBTM), activating agents, and chiral auxiliaries with the goal of control stereoselectivity. These methods were explored through the use of different starting materials like POCl3, triethyl phosphate, methyl phosphordichloradate, and PSCl3. -
Chemical Warfare Agents
Manuscript for Kirk-Othmer Encyclopedia of Chemical Technology August 2019 CHEMICAL WARFARE AGENTS This is the pre-print manuscript of an article published in the Kirk-Othmer Encyclopedia of Chemical Technology: https://onlinelibrary.wiley.com/doi/book/10.1002/0471238961 The published version of the article is available at the Wiley website: https://onlinelibrary.wiley.com/doi/10.1002/0471238961.0308051308011818.a01.pub3 How to cite: Costanzi, S. (2020). Chemical Warfare Agents. In Kirk‐Othmer Encyclopedia of Chemical Technology, (Ed.). doi:10.1002/0471238961.0308051308011818.a01.pub3 Stefano Costanzi Department of Chemistry and Center for Behavioral Neuroscience American University, Washington, D.C. [email protected] Chemical weapons are weapons that exploit the toxicity of chemicals to bring about death or harm. The toxic chemicals on which chemical weapons are based are known as chemical warfare agents. The elimination of this entire category of weapons is the aim of the Convention on the Prohibition of the Development, Production, Stockpiling and Use of Chemical Weapons and on their Destruction, also known as Chemical Weapons Convention or CWC, which was opened for signature in 1993 and entered into force in 1997. Administered and implemented by the Hague- based Organisation for the Prohibition of Chemical Weapons (OPCW), the CWC is an international treaty that enjoys almost universal embracement, having been ratified or acceded by 193 States Parties. Importantly, the CWC poses a complete and absolute ban on chemical weapons, mandating State Parties to renounce “(a) to develop, produce, otherwise acquire, stockpile or retain chemical weapons, or transfer, directly or indirectly, chemical weapons to anyone; (b) to use chemical weapons; (c) to engage in any military preparations to use chemical weapons; (d) to assist, encourage or induce, in any way, anyone to engage in any activity prohibited to a State Party” under the Convention (CWC Article II, Paragraph 1) (1-3).